Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.

Fuchs, M; Jacob, AS; Kaul, H; Kobe, C; Kuhnert, G; Pabst, T; Greil, R; Bröckelmann, PJ; Topp, MS; Just, M; Hertenstein, B; Soekler, M; Vogelhuber, M; Zijlstra, JM; Keller, UB; Krause, SW; Dührsen, U; Meissner ,J; Viardot, A; Eich, HT; Baues, C; Diehl, V; Rosenwald, A; Buehnen, I; von Tresckow, B; Dietlein, M; Borchmann, P; Engert, A; Eichenauer, DA.

Leukemia. 2024 Jan;38(1):160-167. doi: 10.1038/s41375-023-02064-y. Epub 2023 Oct 16.

https://pubmed.ncbi.nlm.nih.gov/37845285/